Clinical trials
Recruiting Lung Neoplasms trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 8 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 3 |
| AstraZeneca | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Amgen | 1 |
| BioNTech SE | 1 |
| Bristol-Myers Squibb | 1 |
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| Hoffmann-La Roche | 1 |
| Latin American Cooperative Oncology Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 17 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Carcinoma | 3 |
| Neoplasm Metastasis | 3 |
| Lung Diseases | 2 |
| Neoplasms | 2 |
| Small Cell Lung Carcinoma | 2 |
| Brain Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Bronchial Neoplasms | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.